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Genetic variations of DICKKOPF family
genes might not be associated with
gastric cancer susceptibility
Juan Wu1,2, Junfeng Zhang2, Zhen Zhan2, Qinhong Cao3 and Zhong Li1*
Abstract
Background: Recent studies have implicated that members of the DICKKOPF (DKK) were causally involved in large
number of human cancers. This study was designed to investigate the relationship between the genetic variations
of DKK family genes and the risk of gastric cancer (GC).
Methods: Six SNPs (single nucleotide polymorphisms) of DKK family genes, including rs2241529 in DKK1, rs3733635,
rs17037102 and rs419764 in DKK2, rs3206824 in DKK3 and rs2073664 in DKK4, were selected and genotyped by
restriction fragment length polymorphism (RFLP) and TaqMan SNP genotyping methods in 409 GC cases and 554
cancer-free controls in the Han population in eastern China.
Results: None of the six SNPs achieved significant association with the overall GC risk and stratified analysis by age,
gender, smoking status, drinking status, tumor location and pathological classification confirmed these non-significant
associations.
Conclusions: Our study indicated that the studied six SNPs of DKKs would not be the risk factors for GC in this
Han Chinese population. Studies of larger population for different ethnicities will be needed to warrant our
findings.
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Background
Based on GLOBOCAN estimates, about 951,600 new gas-
tric cancer (GC) cases and 723,100 deaths occurred in
2012 worldwide [1]. In China, GC rate is predominately
high and GC becomes the third fatal causes of caner,
following lung cancer and liver cancer [2], which induces
enormous burden on the society. The mechanism of gas-
tric carcinogenesis is complex and it is well documented
that environmental elements, including Helicobacter pyl-
ori (HP) infection and life styles, such as diet pattern, alco-
hol consumption and tobacco smoking, may contribute to
the predisposition of GC [3]. Meanwhile, some other fac-
tors may play an important role in GC etiology, such as
epigenetic and genetic effects [4]. Recently, associations
between genetic variants and GC risk have been widely
investigated [5, 6]. However, the results were not always
consistent. Up to date, genetic factors for GC pathogenesis
are still not fully interpreted.
As is well known, deregulation of Wnt/β-catenin pathway
is a hallmark of major gastrointestinal cancers, including
colorectal cancer and GC [7]. Several agonists and antago-
nists could modulate the Wnt/β-catenin pathway and were
involved in the development and progression of malignant
tumors. As a member of agonists and antagonists, the
Dickkopfs (DKKs) were identified as a group of secreted
Wnt modulators. The vertebrates express four DKK pro-
teins (DKK1, -2, -3, and -4) [8]. The cysteine rich secreted
protein products of the DKKs are antagonists of Wnt gly-
coproteins through binding to lipoprotein receptor-related
protein 5/6 (LRP5/6) and Kremen, thus inducing LRP
endocytosis and preventing signaling to β-catenin [9].
Several recent studies have implicated that members
of the DKKs were causally involved in large number of
human cancers including colorectal [10], melanoma [11],
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hepatocellular carcinoma [12], and GC [13]. In clinical
GC specimens, DKK1 mRNA and protein expression
levels were both reported to be significantly upregulated
in GC lesions compared to adjacent noncancerous tissues
[13]. Meanwhile, it would be a predictor of poor prognosis
for GC patients [14].
The genetic variants of DKK family genes influencing
the DKKs expressions on GC was not well elucidated.
We hypothesized that variations of the corresponding
DKKs, especially for those variants located in the gene
functional region, may influence the mRNA and protein
expression levels, and thus the predisposition of the dis-
ease. Therefore, we conducted a hospital-based case-
control study to investigate the association between six
potentially functional variants in DKKs and GC risk with




In this study, 409 GC patients and 554 cancer-free healthy
controls were recruited from the Jiangsu Provincial Hos-
pital of Traditional Chinese Medicine (TCM) from January
2008 to July 2012. The patients were histo-pathologically
confirmed primary GC. GC cases were classified into
intestinal and diffuse subtype according to the Lauren’s
criteria and those with mixed type or not available for
classification were denoted unclassified. Gastric cardia
cancers were defined as tumors located within 20 mm
distal to the gastro-esophageal junction. The healthy con-
trols were selected from the visitors of the health examin-
ation clinic of Jiangsu Provincial Hospital of TCM who
came for an annual check-up during the same study period.
The inclusion and exclusion criteria of the control subjects
referred to the previous study [15]. Peripheral blood sam-
ples were obtained from the GC cases and healthy controls
after the written informed consent was received from each
subject. The study was approved by the Institutional Review
Board of Jiangsu Provincial Hospital of TCM.
Genotyping of DKKs polymorphisms
Genomic DNA was extracted by AxyPrep-96 kit (Axygen,
CA, USA) following the manufacturer’s instructions, and
was quantified spectrophotometrically on NanoDrop2000
(Thermo Scientific, USA). From the public SNP data-
base (http://www.ncbi.nlm.nih.gov/snp), 6 SNPs of the
DKKs (rs2241529 in DKK1; rs3733635, rs17037102 and
rs419764 in DKK2; rs3206824 in DKK3 and rs2073664 in
DKK4) were selected as the candidate SNPs with minor al-
lele frequency more than 10 % in the Han Chinese popula-
tion. All the selected SNPs were located in the potentially
functional region of the genes (5′UTR, exon, and 3′UTR),
and the restriction fragment length polymorphism (RFLP)
method was applied for genotyping the four SNPs
rs3733635, rs17037102, rs3206824, and rs2073664. For
those SNPs (SNPs rs419764 and rs2241529) with no proper
restriction endonuclease, the commercially available
predesigned TaqMan MGB probes and designed
primers (Applied Biosystems, Foster City, CA, USA) were
used for the genotyping. PCR reaction was conducted on
the Veriti® 96-Well Thermal Cycler and the QuantStudio™
Dx Real-Time PCR Instrument (Applied Biosystems, Foster
City, CA, USA), and the reaction condition can be referred
to the previous study [16]. All the primers, enzymes and
TaqMan SNP genotyping assay IDs are shown in Table 2.
Statistical analyses
The two sided χ2 test was applied to compare the geno-
type frequency of the DKKs variants between the GC
cases and the controls. For the association analysis, the
logistic regression analyses were employed to estimate
the association between DKKs genotypes and risk of GC
by computing the odds ratios (ORs) and 95 % confidence
intervals (CIs), all the ORs were adjusted by age (continu-
ous value) and sex (male = 0, female = 1). The common
homozygote was selected as the reference for calculating
the genotype specific ORs. Bonferroni correction was ap-
plied for multiple comparison. The Hardy-Weinberg equi-
librium was tested by the χ2 test for goodness-of-fit and
the p-value less than 0.05 was considered as the significant
level. All the analyses were performed by the SAS 9.1.3
software (SAS Institute, Inc., Cary, NC, USA).
Results
Four hundred nine GC cases and 554 cancer-free healthy
controls were enrolled in this study. The mean age for the
cases and controls were 59.9 ± 11.2 and 53.5 ± 13.4 years,
respectively. The proportion of male subjects was 70.9 %
among the GC cases, and 64.4 % among the controls.
Smokers accounted of 40.1 % among the GC cases, and
31.0 % among the healthy controls. Drinkers were 23.5 %
among the GC cases, and 15.0 % in the healthy controls.
Of the 409 GC cases, 292 (71.4 %) patients were classified
as non-cardia GC and 106 (25.9 %) patients were classified
as cardia GC according the tumor location. Meanwhile,
11 (2.7 %) cases cannot provide tumor location for the
classification. For the GC cases, 383 (94.3 %) pathological
tissues of each patient were available for the histological
type dividing (72 diffuse GC cases and 311 intestinal GC
cases) according to the Lauren’s classification. However,
26 (6.4 %) patients’ pathological tissues were not available
for the classification (Table 1).
The genotype distribution of the six SNPs of DKKs
among the GC cases and the controls is shown in Table 3.
The observed genotype frequencies for all the SNPs
were in Hardy-Weinberg equilibrium among the con-
trols (P > 0.05) (Table 2). Allele frequencies of all the
six SNPs (rs2241529, rs3733635, 17037102, 419764,
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3206824 and rs2073664) among the GC and the con-
trols demonstrated no significant difference (P = 0.42,
0.30, 0.81, 0.25, 0.99 and 0.94, respectively). None of
the six SNPs achieved significant differences for the geno-
type distribution between GC cases and controls (P = 0.67
for rs2241529, 0.44 for rs3733635, 0.94 for 17037102, 0.28
for 419764, 0.90 for3206824 and 0.64 for rs2073664, re-
spectively). Multiple logistic regression analysis revealed
that none of the six SNPs in DKKs were associated with
the overall GC risk (all P values > 0.05) (Table 3). The gen-
etic effects of the six loci were further evaluated on the GC
risk according to the confirmed histological type (intestinal
and diffuse type), and the GA genotype of rs17037102 in
DKK2 was found in association with an increased risk
of diffuse GC with only marginal significance (adjusted
OR = 1.77, 95 % CI: 1.01-3.11, P = 0.05). However, after
Bonferroni correction, the P value reached no statistical
significance (P = 0.14). GA genotype of rs17037102 was
also not found in association with the intestinal GC
(P = 0.42) (Table 4). Meanwhile, according to the site
of tumor origin, it was not found any SNP was in associ-
ation with the risk of either gastric non-cardia cancer or
gastric cardia cancer (all P values >0.05) (Table 3).
Discussion
In this study, rs2241529 in DKK1, rs3733635, rs17037102
and rs419764 in DKK2, rs3206824 in DKK3, and rs2073664
in DKK4 were analyzed among 409 pathologically con-
firmed GC patients and 554 healthy controls. The rela-
tionship between these SNPs and clinic pathologic data,
including pathological subtype (intestinal and diffuse)
and tumor original site (gastric cardia and non-cardia
cancer) was analyzed. Our results showed an insignifi-
cant association, as well as among a series subgroup
analysis and this is the first study to assess these six
variants of DKK family genes on the risk of GC.
Table 1 Distributions of basic characteristics of GC cases and
controls
Variables Controls n = 554 (%) Cases n = 409 (%) P
Age 53.5 ± 13.4 59.9 ± 11.2 <0.001
Gender 0.035
Male 357 (64.4) 290 (70.9)
Female 197 (35.6) 119 (29.1)
Smoke 0.004
No 382 (69.0) 245 (59.9)
Yes 172 (31.0) 164 (40.1)
Drink 0.008
No 471 (85.0) 313 (76.5)









Table 2 The genotyping methods for the SNPs of DKK family genes and Hardy-Weinberg equilibrium for control group









rs2241529 DKK1 TaqMan NA NA NA NA A > G NA C__15873446_20 0.28
rs419764 DKK2 TagMan NA NA NA NA C > T NA C___2543897_10 0.23
rs3733635 DKK2 RFLP Forward ATTTCTGTCCTGAGGCGTGA HinfI 170 T > C TT (170) TC (170,
145, 25) CC (145,25)
NA 0.39
Reverse TCCCCAGGAAGACGCAAAG NA
rs17037102 DKK2 RFLP Forward TCTTAACCCCTCACATCCCG DdeI 151 G > A GG (117, 34) GA (117,




rs3206824 DKK3 RFLP Forward GGAGAGGAGCCTGACTGAAG DdeI 232 G > A 242 (GG) GA (242,
203, 29) AA (203, 29)
NA 0.44
Reverse ATGCACAACACCTCATGCTG NA
rs2073664 DKK4 RFLP Forward GGTCCCATTCCCTTATCCCA EcoNI 248 C > T CC (181, 67) CT




Abbreviations: NA not applicable
*P value for Hardy-Weinberg equilibrium of the studied genotypes in the controls
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DKKs are known as antagonists of Wnt glycoproteins
through binding to lipoprotein LRP5/6 and Kremen,
thus inducing LRP endocytosis and preventing the sig-
naling to β-catenin [9]. Human DKKs have been impli-
cated in several kinds of malignant tumors. For instance,
DKK1 protein was predominantly elevated in tissues of
hepatocellular carcinoma [12], non-small cell lung cancer
[17] and chondrosarcoma [18]. For GC, DKK1 protein
was also expressed higher in malignancy than benign tis-
sues [14] and could refer to poor prognosis [13]. DKK2
protein was seen overexpressed in Ewing sarcoma [19],
colorectal cancer [10] and reduce in melanoma [11]. It
may function as a tumor suppressor or tumor activator
depending on the circumstance. DKK3 and DKK4 could
be referred as the putative tumor suppressors. Tumor
suppression role of DKK3 protein was found in human
cancers in ovary [20], cervix [21] and colon [22]; and
expression of DKK4 protein was reduced in hepatocel-
lular carcinoma tissue and could decrease the β-catenin
protein levels [12].
Variation of the corresponding DKKs, especially in the
potentially functional regions, may influence the mRNA
and protein expression, and thus the risk of tumors. A
small case-control study (210 renal patients vs. 200 con-
trols) reported GA/AA genotype of rs3206824 in DKK3
and GG genotype of rs17037102 in DKK2 were related
















n % n % n % n %
rs2241529(DKK1)
AA 260 46.9 % 184 45.0 % 1.00 42 39.6 % 1.00 136 46.6 % 1.00
AG 247 44.6 % 184 45.0 % 1.07 0.81 1.41 0.64 52 49.1 % 1.35 0.86 2.14 0.20 127 43.5 % 1.01 0.75 1.37 0.94
GG 47 8.5 % 41 10.0 % 1.31 0.82 2.10 0.27 12 11.3 % 1.59 0.76 3.34 0.22 29 9.9 % 1.25 0.74 2.09 0.40
AG + GG/AA 294 53.1 % 225 55.0 % 1.11 0.85 1.44 0.46 64 60.4 % 1.39 0.90 2.16 0.14 156 53.4 % 1.05 0.79 1.40 0.75
rs3733635(DKK2)
TT 335 60.5 % 238 58.2 % 1.00 61 57.5 % 1.00 169 57.9 % 1.00
TC 196 35.4 % 147 35.9 % 1.11 0.84 1.47 0.46 40 37.7 % 1.26 0.80 1.98 0.32 105 36.0 % 1.11 0.82 1.51 0.49
CC 23 4.2 % 24 5.9 % 1.40 0.76 2.59 0.28 5 4.7 % 1.40 0.49 4.02 0.53 18 6.2 % 1.45 0.75 2.79 0.27
TC + CC/AA 219 39.5 % 171 41.8 % 1.14 0.88 1.49 0.33 45 42.5 % 1.28 0.82 1.98 0.28 123 42.1 % 1.15 0.86 1.54 0.35
rs17037102(DKK2)
GG 214 38.6 % 157 38.4 % 1.00 39 36.8 % 1.00 114 39.0 % 1.00
GA 262 47.3 % 191 46.7 % 0.98 0.74 1.31 0.91 50 47.2 % 1.04 0.65 1.67 0.87 135 46.2 % 0.96 0.70 1.31 0.78
AA 78 14.1 % 61 14.9 % 1.08 0.72 1.62 0.70 17 16.0 % 1.30 0.68 2.50 0.42 43 14.7 % 1.04 0.67 1.62 0.85
GA + AA/GG 340 61.4 % 252 61.6 % 1.01 0.77 1.32 0.97 67 63.2 % 1.10 0.70 1.71 0.69 178 61.0 % 0.98 0.73 1.31 0.88
rs419764(DKK2)
CC 304 54.9 % 244 59.7 % 1.00 61 57.5 % 1.00 176 60.3 % 1.00
CT 220 39.7 % 142 34.7 % 0.80 0.61 1.06 0.11 38 35.8 % 0.88 0.56 1.39 0.58 100 34.2 % 0.79 0.58 1.07 0.13
TT 30 5.4 % 23 5.6 % 0.94 0.52 1.68 0.83 7 6.6 % 1.10 0.45 2.71 0.83 16 5.5 % 0.89 0.47 1.70 0.72
CT + TT 250 45.1 % 165 40.3 % 0.82 0.63 1.06 0.13 45 42.5 % 0.91 0.59 1.40 0.66 116 39.7 % 0.80 0.60 1.08 0.14
rs3206824(DKK3)
GG 340 61.4 % 249 60.9 % 1.00 60 56.6 % 1.00 182 62.3 % 1.00
GA 184 33.2 % 140 34.2 % 1.06 0.80 1.40 0.69 41 38.7 % 1.34 0.85 2.11 0.20 96 32.9 % 0.98 0.72 1.34 0.92
AA 30 5.4 % 20 4.9 % 0.94 0.51 1.72 0.84 5 4.7 % 0.87 0.31 2.38 0.78 14 4.8 % 0.89 0.46 1.74 0.73
GA + AA/GG 214 38.6 % 160 39.1 % 1.04 0.80 1.36 0.76 46 43.4 % 1.27 0.82 1.96 0.29 110 37.7 % 0.97 0.72 1.31 0.85
rs2073664(DKK4)
CC 444 80.1 % 331 80.9 % 1.00 85 80.2 % 1.00 236 80.8 % 1.00
CT 105 19.0 % 72 17.6 % 0.91 0.64 1.27 0.56 18 17.0 % 0.82 0.46 1.44 0.49 53 18.2 % 0.93 0.64 1.35 0.71
TT 5 0.9 % 6 1.5 % 1.39 0.41 4.74 0.60 3 2.8 % 2.92 0.62 13.73 0.17 3 1.0 % 0.91 0.21 3.89 0.89
CT + TT/CC 110 19.9 % 78 19.1 % 0.93 0.67 1.29 0.66 21 19.8 % 0.91 0.53 1.56 0.73 56 19.2 % 0.93 0.65 1.34 0.70
aORs were adjusted by age and gender
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with decreased risk of renal cancer and cancer deaths, re-
spectively, in Japanese population [23]. However, our study
did not reappear such an association in GC risk in Chinese
population. The results suggest a considerable heteroge-
neous effect of these two SNPs among various cancer types
and/or different genetic backgrounds. Alanazi et al.,
[24] reported 2-fold reduced breast cancer risk in women
with GG genotype as compared to AA genotype in case of
rs6485350 in DKK3 [24]. Furthermore, GG genotype and
AG genotype showed enhanced protection against estro-
gen receptor positive tumor and estrogen receptor nega-
tive tumor, respectively. SNP rs3763511 in DKK4 was
related with age independent increased breast cancer risk
of estrogen receptor negative tumor. Despite the signifi-
cant findings, two loci located in the introns in the cor-
responding gene and beyond our selection range. The
significant association could be explained by the linkage
disequilibrium with the potentially functional loci, or
the observed association may be due to chance with
small sample size (99 patients vs. 93 controls).
Several limitations of the present study need to be
mentioned. First, the mean age in the GC cases was sig-
nificantly higher than that of the healthy controls, and
the age itself may be an independent risk element for





Adjusted OR (95 % CI)a P Diffuse
(N = 72)
Adjusted OR (95 % CI)a P
n % n % n %
rs2241529(DKK1)
AA 260 46.9 % 141 45.3 % 1.00 29 40.3 % 1.00
AG 247 44.6 % 142 45.7 % 1.10 0.82 1.49 0.52 34 47.2 % 1.25 0.73 2.11 0.42
GG 47 8.5 % 28 9.0 % 1.10 0.65 1.87 0.72 9 12.5 % 1.75 0.78 3.96 0.18
AG + GG/AA 294 53.1 % 170 54.7 % 1.10 0.83 1.47 0.51 43 59.7 % 1.33 0.80 2.19 0.27
rs3733635(DKK2)
TT 335 60.5 % 190 61.1 % 1.00 38 52.8 % 1.00
TC 196 35.4 % 100 32.2 % 0.98 0.72 1.34 0.91 32 44.4 % 1.48 0.89 2.45 0.13
CC 23 4.2 % 21 6.8 % 1.58 0.84 3.00 0.16 2 2.8 % 0.77 0.17 3.39 0.73
TC + CC/AA 219 39.5 % 121 38.9 % 1.05 0.78 1.41 0.75 34 47.2 % 1.40 0.85 2.30 0.18
rs17037102(DKK2)
GG 214 38.6 % 124 39.9 % 1.00 20 27.8 % 1.00
GA 262 47.3 % 139 44.7 % 0.88 0.64 1.20 0.42 43 59.7 % 1.77 1.01 3.11 0.05*
AA 78 14.1 % 48 15.4 % 1.08 0.70 1.66 0.74 9 12.5 % 1.27 0.55 2.92 0.57
GA + AA/GG 340 61.4 % 187 60.1 % 0.92 0.69 1.24 0.59 52 72.2 % 1.66 0.96 2.86 0.07
rs419764(DKK2)
CC 304 54.9 % 179 57.6 % 1.00 48 66.7 % 1.00
CT 220 39.7 % 112 36.0 % 0.87 0.64 1.18 0.36 23 31.9 % 0.66 0.39 1.12 0.13
TT 30 5.4 % 20 6.4 % 1.14 0.61 2.10 0.69 1 1.4 % 0.20 0.03 1.48 0.11
CT + TT 250 45.1 % 132 42.4 % 0.90 0.68 1.20 0.48 24 33.3 % 0.60 0.36 1.02 0.06
rs3206824(DKK3)
GG 340 61.4 % 193 62.1 % 1.00 38 52.8 % 1.00
GA 184 33.2 % 103 33.1 % 0.99 0.73 1.35 0.97 29 40.3 % 1.43 0.85 2.41 0.17
AA 30 5.4 % 15 4.8 % 0.87 0.45 1.69 0.68 5 6.9 % 1.47 0.54 4.04 0.45
GA + AA/GG 214 38.6 % 118 37.9 % 0.98 0.73 1.31 0.87 34 47.2 % 1.44 0.88 2.36 0.15
rs2073664(DKK4)
CC 444 80.1 % 252 81.0 % 1.00 60 83.3 % 1.00
CT 105 19.0 % 54 17.4 % 0.88 0.60 1.28 0.49 11 15.3 % 0.76 0.39 1.50 0.43
TT 5 0.9 % 5 1.6 % 1.55 0.43 5.62 0.50 1 1.4 % 1.30 0.15 11.48 0.81
CT + TT/CC 110 19.9 % 59 19.0 % 0.91 0.63 1.31 0.61 12 16.7 % 0.79 0.41 1.52 0.47
*P value reached no statistical significance by Bonferroni correction
aORs were adjusted by age and gender
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GC. However, all the odds ratio of six SNPs was adjusted
by age and gender to minimize the potential confounding
effect. Second, environmental factors, such as H. pylori in-
fection was not considered in this study, which may dem-
onstrate the non-genetic factors on the risk of GC, and
further explain the gene-environmental interaction on
GC. Further studies with large sample size are warranted
to evaluate the contribution of gene-environment inter-
action on GC.
Conclusions
Our study indicated that the studied six SNPs of DKKs
would not be the risk factors for GC in this Han Chinese
population. However, analysis of these SNPs incorporat-
ing with environmental factors may further explain the
risk on GC.
Abbreviations
CI, confidence interval; DKK, DICKKOPF; GC, gastric cancer; LRP5/6,
lipoprotein receptor-related protein 5/6; OR, odds ratio; RFLP, restriction
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